Thyrocare Technologies is trading 3.96% upper at Rs 1,023.40 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 1,028.90 & 971.05. Thyrocare Technologies has given 8.04% in this year & -1.16% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 39.38 as compared to the sector P/E of 23.24.There are 1 analysts who have initiated coverage on Thyrocare Technologies. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 21.70 Crores in its last quarter.Listed peers of Thyrocare Technologies include Healthcare Global Enterprises (0.89%), Kovai Medical Cente And Hospital (-0.69%), Thyrocare Technologies (3.96%).The Mutual Fund holding in Thyrocare Technologies was at 12.97% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Thyrocare Technologies was at 2.41% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jun 13, 2025, 01:27 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Healthcare Global Enterprises | Bullish | 549.60 | 0.89 | 7,676.26 | 173.79 | 8.25 | - | 149.57 |
Kovai Medical Cente And Hospital | Neutral | 5,937.00 | -0.69 | 6,495.39 | 31.66 | 6.09 | 0.17 | 34.88 |
Thyrocare Technologies | Bullish | 1,023.40 | 3.96 | 5,403.88 | 58.27 | 9.65 | 1.81 | 3.09 |
Indraprastha Medical Corp | Bearish | 409.25 | -0.46 | 3,755.75 | 24.05 | 6.49 | 1.07 | 5.12 |
Artemis Medicare Services | Bearish | 260.40 | 0.04 | 3,625.88 | 49.95 | 4.36 | 0.17 | 29.74 |
Meeting Date | Purpose |
---|---|
2025-04-23 | Audited Results & Final Dividend |
2025-01-23 | Quarterly Results |
2024-10-23 | Quarterly Results |
2024-07-23 | Quarterly Results |
2024-05-14 | Audited Results & Final Dividend |
Thyrocare Technologies is trading at 1023.40 as on Fri Jun 13 2025 09:59:01. This is 3.96% upper as compared to its previous closing price of 984.40.
The market capitalization of Thyrocare Technologies is 5403.88 Cr as on Fri Jun 13 2025 09:59:01.
The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Thyrocare Technologies is 1072.45 whereas the 52 wk low is 605.05
Thyrocare Technologies can be analyzed on the following key metrics -
Thyrocare Technologies reported a net profit of 91.51 Cr in 2025.
The Mutual Fund Shareholding was 12.97% at the end of 31 Mar 2025.